Cardinal Health’s 7.21% Drop Amid $1.13B Surge in Volume Rank 73 as $1.9B Solaris Acquisition Expands Urology Reach

Cardinal Health (CAH) closed August 12, 2025, with a 7.21% decline, despite a 130.07% surge in trading volume to $1.13 billion, ranking it 73rd in daily activity. The drop followed the announcement of a $1.9 billion cash acquisition of Solaris Health, a leading urology-focused management services organization (MSO). The deal adds over 750 providers across 14 states, expanding Cardinal’s multi-specialty platform, The Specialty Alliance, to approximately 3,000 providers in 32 states post-close.

The acquisition accelerates Cardinal’s strategy to dominate high-margin urology care, building on recent purchases of Urology America and Potomac Urology. Solaris Health’s integration is expected to slightly boost non-GAAP earnings per share within 12 months post-closure. The company will finance the transaction using existing cash and new debt, with a 18-24 month timeline for debt reduction while maintaining prior share repurchase plans. The deal is slated to close by year-end 2025, pending regulatory and physician approvals.

A backtest of a strategy buying the top 500 stocks by daily volume and holding for one day yielded a $2,940 profit between December 2021 and August 2025. The approach recorded a maximum drawdown of -$1,960, an average daily return of 0.24%, and a Sharpe ratio of 0.67 over the period, peaking at 1.2 in its best four-year stretch.